Treating Dengue, Schistosomiasis, Chagas Disease and Leishmaniasis

According to PAHO/WHO neglected or ‘forgotten’ infectious diseases are often parasitic diseases which primarily affect the most vulnerable communities. These illnesses often impact on those living in extreme poverty who have terrible access to health services, particularly those in very rural areas or shantytowns. These factors of being poor and being marginalised exacerbate the consequences of the disease compared with …

Merck enters the Ebola Vaccine Race in NewLink Partnership

Merck obtains the rights to NewLink genetics’ experimental Ebola Vaccine, putting pressure on GSK Merck has struck a agreement with NewLink Genetics to licence their investigational Ebola vaccine, rVSV-EBOV. The $50 million agreement gives Merck exclusive rights to develop, manufacture, and distribute the vaccine across the world. This partnership should allow NewLink to keep pace with the huge effort by …

Designing the Next Generation of Vaccines

Sylvie Bertholet, PhD Head In vivo Immunology, Novartis Vaccines & Diagnostics joined us last year at the World Vaccine Congress Europe to present on ‘Designing the Next Generation of Vaccines’ Download this presentation now to find out more about: Designing the Next Generation Vaccines What is a self-amplifying mRNA (replicon)? How does SAM work? A Synthetic Flu Vaccine – SAM(H7) …

Polio Set To get The Nanopatch Treatment from Vaxxas

Vaxxas announces a WHO funded project to evaluate the delivery of polio vaccine using Nanopatch Australian company Vaxxas last week announced the initiation of a research project designed to evaluate the commercialisation prospects of Nanopatch, their microneedle platform for the delivery of polio vaccine. Vaxxas’ Nanopatch consists of a 1cm2 square of silicon with around 20,000 microprojections on its surface. Penetrating …

Inovio Presents Phase II Clinical Efficacy Data at the 15th World Vaccine Congress

With the 15th World Vaccine Congress on 13 – 15 October in Brussels is just next month I conducted an interview to one of our key speakers, Dr. Niranjan Y. Sardesai (COO, Inovio Pharmaceuticals, Inc.) to give you further insight into his new exciting clinical data and current challenges in developing cancer DNA vaccines.  Dr. Sardesai has broad development and …

From Cedar and Peanut allergies to Cancer Vaccines and Immunotherapeutics: This is the future of DNA vaccine technology

One company stands on the brink of a revolution in vaccine technology that has the potential to change millions of lives with innovative DNA and RNA vaccines See the future of DNA vaccines: download the report For over 20 years the vaccines industry has pushed towards the goal of creating an effective DNA vaccine. But thus far the industry has …

Researchers at University College Cork in Ireland have developed a patch that delivers small doses of a vaccine through microscopic needles

UCC Developing Vaccine Patch To Combat Malaria

Researchers at University College Cork in Ireland have developed a patch that delivers small doses of a vaccine through microscopic needles A new malaria vaccine administered through a micro-needle patch has been developed by scientists at the school of pharmacy at the University College Cork in Ireland. The patch itself is composed of microscopic silicon needles which deliver the vaccine …

A new vaccine has been found to stop rhesus macaque moneys from infection with SIV, the monkey form of the HIV virus

New Vaccine Unexpectedly Suppresses HIV Infection In Monkeys

A new vaccine has been found to stop rhesus macaque monkeys from being infected with SIV, the monkey form of the HIV virus An international research team, with scientists based in Paris-Descartes University in France, as well as the University of Chinese Medicine in Guangzhou, China, has developed a new orally administered vaccine that was found to block the SIV …